Prof. Jianjun Qin 秦建军
Chief Physician, Professor
Department of Thoracic Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and multidisciplinary treatment of esophageal, cardia, lung, and mediastinal tumors. Specializes in thoracoscopic minimally invasive surgery.
Dr. Qin holds a medical doctorate and is a Professor and Chief Physician at the Cancer Hospital, Chinese Academy of Medical Sciences. Trained at West China University of Medical Sciences (entered 1992, PhD 2003). With over 10 years of experience in thoracoscopic radical surgeries for lung and esophageal cancer, Dr. Qin focuses on refined surgical processes and precise staging. A recipient of the National Natural Science Foundation grant, Dr. Qin has published over 30 academic papers.
Professional roles
- Vice Chair, First Youth Committee, Thoracic Surgery Branch, Chinese Medical Doctor Association
- Member, Esophageal Cancer Professional Committee, China Anti-Cancer Association
- Section Editor, Journal of Thoracic Disease
- Editorial Board Member, Annals of Esophagus
Name order: in Chinese the family name comes first (Qin Jianjun). Papers usually list the name as Jianjun Qin or Qin J.
Selected publications
53 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Biol Ther, 2024 (senior author): S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study. PubMed 39462770
- Ann Surg Oncol, 2024 (senior author): Analysis of the Trends and Influencing Factors for Postoperative Cough in Patients with Esophageal Cancer Based on Patient-Reported Outcomes. PubMed 38762645
- Nat Med, 2024 (first author): Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial. PubMed 38956195
- J Thorac Dis, 2022 (senior author): Older patients more likely to die from cancer-related diseases than younger with stage IA non-small cell lung cancer: a SEER database analysis. PubMed 35813764
- Biochem Biophys Res Commun, 2021 (senior author): CircRNA CircZMYM4 inhibits the growth and metastasis of lung adenocarcinoma via the miR-587/ODAM pathway. PubMed 34634673
- Thorac Cancer, 2019 (first author): Comparative study of esophagectomy, endoscopic therapy, and radiotherapy for cT1N0M0 esophageal cancer in elderly patients: A SEER database analysis. PubMed 31199600
- Thorac Cancer, 2018 (senior author): Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy. PubMed 29893036
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion